Charlottesville, VA - January 25, 2023

Liquet Medical Inc. is excited to announce a new member of the Board of Directors as of January 24, 2023. This addition builds on Liquet Medical’s Board expertise by incorporating a proven leader with legal prowess and multiple early-stage company successes. “We are thrilled to welcome Bill Porter to the Liquet Medical team,” says CEO John Schindler. “We’ve had the privilege of working with Bill over the last several years. He brings a tremendous breadth and depth of knowledge that will assuredly make a difference as we move towards commercialization of our first product, the Versus Intelligent Catheter, later this calendar year.”

Bill Porter, J.D.

Mr. Porter is Managing Director of QDS Capital, CEO of RefluxRaft Corporation, and is a seasoned San Francisco Bay area business operations executive with over 20+ years of expertise building and scaling early-stage companies focused on enterprise software, AI and machine learning, and information technology. Bill was the Chief Operating Officer of ThousandEyes, a network intelligence SaaS Company acquired by Cisco in 2019. He is an adjunct faculty member at University of Virginia Law School and he holds undergraduate and law degrees from Duke University.

Liquet Medical Inc.

Liquet Medical is a development stage medical device company. Their first product to market will be the Versus™ Catheter – a localized drug delivery catheter to treat blood clots in the lungs. This device allows for a personalized approach to each patient through real-time biometric data monitoring. It will also speed time-to-treatment and lower hospital costs.